Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 6 555-561, Copyright © 1993 by American Association for Cancer Research

ARTICLES

Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children

CP Wild, M Fortuin, F Donato, HC Whittle, AJ Hall, CR Wolf and R Montesano
International Agency for Research on Cancer, Lyon, France.

The relative contribution of, and possible mechanism of interaction between, aflatoxin and hepatitis B virus (HBV) in the development of primary hepatocellular carcinoma can be better investigated now that markers of individual exposure to both factors are available. In this study, blood samples were collected over a 1-month period from 117 children aged 3 to 4 years, resident in Kuntair or Kerr Cherno in the Upper Niumi District of The Gambia. Samples were analyzed for aflatoxin-albumin (AF-alb) adducts, markers of HBV infection, liver enzymes [serum alanine aminotransferase (ALT)] as markers of liver damage, and glutathione S-transferase M1 genotype. All but two children showed detectable serum AF-alb with levels ranging from 2.2 to 250.4 pg aflatoxin B1-lysine equivalent/mg albumin. There was a significant positive correlation between AF-alb and ALT (r = 0.4; P < 0.001). HBV carriers showed moderately higher levels of AF-alb than noncarriers but the difference was not statistically significant and the association between AF-alb and ALT was unchanged when the HBV carriers were excluded from the analysis, suggesting that factors other than HBV infection contributed to the association. The null glutathione S-transferase M1 genotype was infrequent (17.7%) in this population and was not associated with any difference in AF-alb adduct levels compared to glutathione S-transferase M1-positive individuals. However, the percentage of individuals with the null genotype varied significantly between ethnic groups with 32.1% in Fula, 8.8% in Mandinka, and 13.3% in Wollof.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				T. Peng, L.-Q. Li, M.-H. Peng, Z.-M. Liu, T.-W. Liu, Y. Guo, K.-Y. Xiao, Z. Qin, X.-P. Ye, X.-S. Mo, et al. Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1 a multi-center and multi-biomarker study Carcinogenesis, November 1, 2007; 28(11): 2347 - 2354. [Abstract] [Full Text] [PDF]

				P. C Turner, A. C Collinson, Y. B. Cheung, Y. Gong, A. J Hall, A. M Prentice, and C. P Wild Aflatoxin exposure in utero causes growth faltering in Gambian infants Int. J. Epidemiol., October 1, 2007; 36(5): 1119 - 1125. [Abstract] [Full Text] [PDF]

				G. D. Kirk, E. Bah, and R. Montesano Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa Carcinogenesis, October 1, 2006; 27(10): 2070 - 2082. [Abstract] [Full Text] [PDF]

				P. C. Turner, A. Sylla, S.-Y. Kuang, C. L. Marchant, M. S. Diallo, A. J. Hall, J. D. Groopman, and C. P. Wild Absence of TP53 Codon 249 Mutations in Young Guinean Children with High Aflatoxin Exposure Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2053 - 2055. [Abstract] [Full Text] [PDF]

				G. D. Kirk, P. C. Turner, Y. Gong, O. A. Lesi, M. Mendy, J. J. Goedert, A. J. Hall, H. Whittle, P. Hainaut, R. Montesano, et al. Hepatocellular Carcinoma and Polymorphisms in Carcinogen-Metabolizing and DNA Repair Enzymes in a Population with Aflatoxin Exposure and Hepatitis B Virus Endemicity Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 373 - 379. [Abstract] [Full Text] [PDF]

				K. A. McGlynn, K. Hunter, T. LeVoyer, J. Roush, P. Wise, R. A. Michielli, F.-M. Shen, A. A. Evans, W. T. London, and K. H. Buetow Susceptibility to Aflatoxin B1-related Primary Hepatocellular Carcinoma in Mice and Humans Cancer Res., August 1, 2003; 63(15): 4594 - 4601. [Abstract] [Full Text] [PDF]

				Y. Gong, S Egal, A Hounsa, P. Turner, A. Hall, K. Cardwell, and C. Wild Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning Int. J. Epidemiol., August 1, 2003; 32(4): 556 - 562. [Abstract] [Full Text] [PDF]

				C.P. Wild and P.C. Turner The toxicology of aflatoxins as a basis for public health decisions Mutagenesis, November 1, 2002; 17(6): 471 - 481. [Abstract] [Full Text] [PDF]

				S.-Y. Chen, C.-J. Chen, S.-R. Chou, L.-L. Hsieh, L.-Y. Wang, W.-Y. Tsai, H. Ahsan, and R. M. Santella Association of Aflatoxin B1-Albumin Adduct Levels with Hepatitis B Surface Antigen Status among Adolescents in Taiwan Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1223 - 1226. [Abstract] [Full Text] [PDF]

				J. D. Groopman and T. W. Kensler The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis, January 1, 1999; 20(1): 1 - 11. [Full Text] [PDF]